J&J Rep Grilled On 'Low Abuse Potential' Opioid Claim
Johnson & Johnson's designated corporate representative faced hours of questioning Friday over sales reps' documented practice of telling doctors that its fentanyl patch's potential for abuse was low, dominating the fourth...To view the full article, register now.
Already a subscriber? Click here to view full article